UTS Research Centre

Institute of Biomedical Materials and Devices (IBMD)

PEOPLE

    • Associate Professor
    • School of Electrical Mechanical and Biomedical Eng
    • Associate ProfessorSchool of Electrical Mechanical and Biomedical Eng

    A/Prof. Yuen Yee Cheng is a teaching and research academic, with expertise in molecular and cellular biology, who is developing new biomarkers and therapeutics for hard-to-treat diseases. She employs cutting-edge technologies, that integrate microRNA (miRNA) into biomedicine, with a goal of translating laboratory discoveries into clinical applications that directly improve patient outcomes. Her discovery of miRNA-16’s ability to enhance immunotherapy response has reshaped our understanding of miRNA’s role in immune regulation, resulting in high-impact publications and successful peer-reviewed grants from iCare and Tour de Cure. These advances have led to the identification of a new immunotherapy combination achieving a 90% response rate in the epithelioid subtype of mesothelioma. 


    With more than 15 years of research experience in Hong Kong and Australia, A/Prof. Cheng’s work focuses on developing novel biomarkers and treatments for occupational lung diseases. She is internationally recognised for her research on mesothelioma, an aggressive lung cancer linked to asbestos exposure. Since joining UTS, she has expanded her research to include silicosis, a fatal lung disease caused by the inhalation of fine particulate silica dust arising from cutting, grinding or drilling in the workplace.


    Her strong commitment to translational research, has resulted in two clinical trials to treat mesothelioma. One trial conducted in Australia, enrolled 27 end-stage patients, with one end-stage patient achieving cancer-free survival for 32 weeks. Her innovations have led to three patents, two are currently being commercialised by her industry partners MedAir and Hon-E Haven, bridging research and real-world applications.


    A/Prof. Cheng leads multidisciplinary collaborations across 11 institutions and with 4 industry partners worldwide. She is experienced in biobank management, having served as a human biobank leader, further strengthening her translational pipeline and access to critical biospecimens. In recognition for her leadership in the field, she was invited by the World Health Organization (WHO) to speak and co-lead workshops in Fiji and The Philippines to train healthcare professionals in mesothelioma diagnosis. Notably, the team identified the first confirmed case of mesothelioma in Fiji, and she continues to advise on diagnostic improvements.


    A/Prof. Cheng is ranked in the top 0.02% of mesothelioma researchers in Australia and the top 0.65% globally (Expertscape, 2013–2023). Currently, she has published 112 peer-reviewed papers, 63 in the past 5 years in high-impact journals such as Nature Nanotechnology, Molecular Cancer, and Biofabrication. Her work has been cited over 4,500 times and she has an h-index of 37. She has secured $10 million in competitive research funding, including $2.5 million as lead Chief Investigator, and is the most funded researcher supported by iCare NSW.


    A/Prof. Cheng is a member of Lung Foundation Australia, the American Association of Cancer Research and the Thoracic Oncology Group of Australasia.

     

    RESEARCH AREAS

    Disease biomarker discovery and development
    The research aims to identify novel, highly specific biomarkers that can distinguish disease states with precision, enabling earlier, more accurate and less invasive diagnostic strategies. It has a particular focus on epigenetic biomarkers, including DNA methylation, circular RNAs and microRNAs (miRNA), due to their exceptional stability in blood circulation. These molecular signatures hold strong potential for transforming current clinical workflows by enabling timely intervention and guiding treatment decisions more effectively. In 2023, A/Prof. Cheng began her collaboration with Prof. David Gallego-Ortega to apply single-cell sequencing for the discovery of novel biomarkers in mesothelioma and silicosis. She also explored the use of digital PCR technology, was the first in Australia to publish on the use of digital PCR as a replacement for the labor-intensive in situ hybridization method for studying p16 deletion in mesothelioma.


    3D organoid development to study diseases and therapies
    The research focuses on developing advanced 3D organoid models for clinical testing of novel therapies targeting diseases such as mesothelioma, silicosis, and others. These models are designed to overcome the limitations of traditional 2D cell cultures, which fail to accurately replicate the complex tissue architecture, cell–cell interactions, and drug response dynamics observed in human tissues. By engineering 3D organoids using diverse biomaterials and incorporating multiple cell types, the research aims to more accurately mimic in vivo and disease conditions. This approach not only improves drug screening reliability, but also advances personalised medicine, while reducing reliance on animal models.
     
    Nanotechnologies for the development of precise delivery systems for disease therapeutics
    Over the past 15 years, A/Prof. Cheng's research in microRNAs (miRNAs) has demonstrated their potential as a therapeutic strategy for mesothelioma, including the ability to overcome chemotherapy resistance and enhance the limited efficacy of immunotherapy. As miRNA-based therapies require an effective delivery system to target specific cells, her work has focused on developing such delivery mechanisms. This research has led to the successful completion of a Phase I clinical trial using miRNA therapy for mesothelioma. From this experience, she recognised that advancing nanotechnology for miRNA delivery is critical to realising the full therapeutic potential of miRNAs in clinical settings. Furthermore, the nanomaterials developed for targeted miRNA delivery hold promise for application across a range of disease conditions beyond mesothelioma.

    A/Prof. Yuen Yee Cheng is a teaching and research academic, with expertise in molecular and cellular biology, who is developing new biomarkers and therapeutics for hard-to-treat diseases. She employs cutting-edge technologies, that integrate microRNA (miRNA) into biomedicine, with a goal of translating laboratory discoveries into clinical applications that directly improve patient outcomes. Her discovery of miRNA-16’s ability to enhance immunotherapy response has reshaped our understanding of miRNA’s role in immune regulation, resulting in high-impact publications and successful peer-reviewed grants from iCare and Tour de Cure. These advances have led to the identification of a new immunotherapy combination achieving a 90% response rate in the epithelioid subtype of mesothelioma. 


    With more than 15 years of research experience in Hong Kong and Australia, A/Prof. Cheng’s work focuses on developing novel biomarkers and treatments for occupational lung diseases. She is internationally recognised for her research on mesothelioma, an aggressive lung cancer linked to asbestos exposure. Since joining UTS, she has expanded her research to include silicosis, a fatal lung disease caused by the inhalation of fine particulate silica dust arising from cutting, grinding or drilling in the workplace.


    Her strong commitment to translational research, has resulted in two clinical trials to treat mesothelioma. One trial conducted in Australia, enrolled 27 end-stage patients, with one end-stage patient achieving cancer-free survival for 32 weeks. Her innovations have led to three patents, two are currently being commercialised by her industry partners MedAir and Hon-E Haven, bridging research and real-world applications.


    A/Prof. Cheng leads multidisciplinary collaborations across 11 institutions and with 4 industry partners worldwide. She is experienced in biobank management, having served as a human biobank leader, further strengthening her translational pipeline and access to critical biospecimens. In recognition for her leadership in the field, she was invited by the World Health Organization (WHO) to speak and co-lead workshops in Fiji and The Philippines to train healthcare professionals in mesothelioma diagnosis. Notably, the team identified the first confirmed case of mesothelioma in Fiji, and she continues to advise on diagnostic improvements.


    A/Prof. Cheng is ranked in the top 0.02% of mesothelioma researchers in Australia and the top 0.65% globally (Expertscape, 2013–2023). Currently, she has published 112 peer-reviewed papers, 63 in the past 5 years in high-impact journals such as Nature Nanotechnology, Molecular Cancer, and Biofabrication. Her work has been cited over 4,500 times and she has an h-index of 37. She has secured $10 million in competitive research funding, including $2.5 million as lead Chief Investigator, and is the most funded researcher supported by iCare NSW.


    A/Prof. Cheng is a member of Lung Foundation Australia, the American Association of Cancer Research and the Thoracic Oncology Group of Australasia.

     

    RESEARCH AREAS

    Disease biomarker discovery and development
    The research aims to identify novel, highly specific biomarkers that can distinguish disease states with precision, enabling earlier, more accurate and less invasive diagnostic strategies. It has a particular focus on epigenetic biomarkers, including DNA methylation, circular RNAs and microRNAs (miRNA), due to their exceptional stability in blood circulation. These molecular signatures hold strong potential for transforming current clinical workflows by enabling timely intervention and guiding treatment decisions more effectively. In 2023, A/Prof. Cheng began her collaboration with Prof. David Gallego-Ortega to apply single-cell sequencing for the discovery of novel biomarkers in mesothelioma and silicosis. She also explored the use of digital PCR technology, was the first in Australia to publish on the use of digital PCR as a replacement for the labor-intensive in situ hybridization method for studying p16 deletion in mesothelioma.


    3D organoid development to study diseases and therapies
    The research focuses on developing advanced 3D organoid models for clinical testing of novel therapies targeting diseases such as mesothelioma, silicosis, and others. These models are designed to overcome the limitations of traditional 2D cell cultures, which fail to accurately replicate the complex tissue architecture, cell–cell interactions, and drug response dynamics observed in human tissues. By engineering 3D organoids using diverse biomaterials and incorporating multiple cell types, the research aims to more accurately mimic in vivo and disease conditions. This approach not only improves drug screening reliability, but also advances personalised medicine, while reducing reliance on animal models.
     
    Nanotechnologies for the development of precise delivery systems for disease therapeutics
    Over the past 15 years, A/Prof. Cheng's research in microRNAs (miRNAs) has demonstrated their potential as a therapeutic strategy for mesothelioma, including the ability to overcome chemotherapy resistance and enhance the limited efficacy of immunotherapy. As miRNA-based therapies require an effective delivery system to target specific cells, her work has focused on developing such delivery mechanisms. This research has led to the successful completion of a Phase I clinical trial using miRNA therapy for mesothelioma. From this experience, she recognised that advancing nanotechnology for miRNA delivery is critical to realising the full therapeutic potential of miRNAs in clinical settings. Furthermore, the nanomaterials developed for targeted miRNA delivery hold promise for application across a range of disease conditions beyond mesothelioma.

    • 3 Good Health and Well Being
    • 9 Industry, Innovation and Infrastructure
    • Academic
    Disciplines
    • Nanomedicine
    • Medical genetics (excl. cancer genetics)
    • Biochemistry and cell biology
    • Associate Head Of School (Teaching And Learning)
    • Molecular Biotechnology Discipline
    • Associate Head Of School (Teaching And Learning)Molecular Biotechnology Discipline

    Charles obtained his Science degree with Honours in Pharmacology from Monash University in 1996. He then completed his PhD in Biophysics at Swinburne University of Technology in 2002, where he investigated the effects of mobile phone radiation on calcium levels in T lymphocytes.

    His first post-doctoral position took him to Keele University in England, where he worked under the mentorship of Prof. Jon Dobson to explore the interactions between biogenic magnetic nanoparticles and mobile phone radiation. Returning to Melbourne, Charles collaborated with Prof. Min Gu at the Centre for Micro-Photonics at Swinburne University of Technology, contributing to the development of the world’s first non-linear endoscope.

    Charles was awarded two Marie Curie Transfer of Knowledge Fellowships. The first fellowship was at the Tyndall National Institute in Cork, Ireland, where he assisted in developing fluorescence-based point-of-care diagnostic devices. The second fellowship took him to University Hospital Jena, Germany, where he worked with biomolecular photonics expert Prof. Christoph Biskup to develop novel fluorescent ion nanosensors. From 2010 to 2013, Charles conducted research on lipid-protein interactions of mechanosensitive ion channels in the laboratory of Prof. Boris Martinac at the Victor Chang Cardiac Research Institute.

    In 2014, Charles was appointed Senior Lecturer at the University of Technology Sydney (UTS). He became Team Leader of the Molecular Biosciences Team within the newly formed School of Life Sciences in 2015. By 2018, he was Deputy Leader of the Biology and Biotechnology Discipline, and in 2020, he was appointed Program Director for the Biomedical Science degrees and was then also made a Program Director for Medical Science and Advanced Science (Pre-Med) degrees in 2022. From 2021-2025, Charles was the Director of HDR Programs in the Faculty of Science. He is currently Associate Head of School (Teaching and Learning) in the School of Maths and Physical Sciences.

    At UTS, Charles established the Membrane Biophysics Lab in the School of Life Sciences. He leads projects focused on understanding membrane-ion interactions, membrane-peptide interactions, and the development of novel membrane-based biosensors.

    Charles obtained his Science degree with Honours in Pharmacology from Monash University in 1996. He then completed his PhD in Biophysics at Swinburne University of Technology in 2002, where he investigated the effects of mobile phone radiation on calcium levels in T lymphocytes.

    His first post-doctoral position took him to Keele University in England, where he worked under the mentorship of Prof. Jon Dobson to explore the interactions between biogenic magnetic nanoparticles and mobile phone radiation. Returning to Melbourne, Charles collaborated with Prof. Min Gu at the Centre for Micro-Photonics at Swinburne University of Technology, contributing to the development of the world’s first non-linear endoscope.

    Charles was awarded two Marie Curie Transfer of Knowledge Fellowships. The first fellowship was at the Tyndall National Institute in Cork, Ireland, where he assisted in developing fluorescence-based point-of-care diagnostic devices. The second fellowship took him to University Hospital Jena, Germany, where he worked with biomolecular photonics expert Prof. Christoph Biskup to develop novel fluorescent ion nanosensors. From 2010 to 2013, Charles conducted research on lipid-protein interactions of mechanosensitive ion channels in the laboratory of Prof. Boris Martinac at the Victor Chang Cardiac Research Institute.

    In 2014, Charles was appointed Senior Lecturer at the University of Technology Sydney (UTS). He became Team Leader of the Molecular Biosciences Team within the newly formed School of Life Sciences in 2015. By 2018, he was Deputy Leader of the Biology and Biotechnology Discipline, and in 2020, he was appointed Program Director for the Biomedical Science degrees and was then also made a Program Director for Medical Science and Advanced Science (Pre-Med) degrees in 2022. From 2021-2025, Charles was the Director of HDR Programs in the Faculty of Science. He is currently Associate Head of School (Teaching and Learning) in the School of Maths and Physical Sciences.

    At UTS, Charles established the Membrane Biophysics Lab in the School of Life Sciences. He leads projects focused on understanding membrane-ion interactions, membrane-peptide interactions, and the development of novel membrane-based biosensors.

    • 3 Good Health and Well Being
    • 13 Climate Action
    • Academic
    • Masters Research or PhD student supervision
    Disciplines
    • Biochemistry and cell biology
    • Medical physiology
    • Microbiology
    • Professor
    • Chemistry Discipline
    • ProfessorChemistry Discipline
    Dr Lei Jiang is a Professor at Technical Institute of Physics and Chemistry, Chinese Academy of Sciences (TIPC) and University of Technology Sydney (UTS). He is an academician of the Chinese Academy of Sciences, Academy of Sciences for the Developing World, National Academy of Engineering (USA), Australian Academy of Science and Academia Europaea.
    Lei received his Bachelor’s and Master’s degrees from Jilin University, and PhD from the University of Tokyo. He worked as a post-doctoral fellow with Prof. Akira Fujishima and then as a senior researcher in the Kanagawa Academy of Sciences and Technology. In 1999, he joined Institute of Chemistry, Chinese Academy of Sciences. In 2015, he and his group moved to TIPC. He joined UTS in 2023 as a part-time professor.
    His scientific interests focus on bio-inspired, smart, multi-scale interfacial materials with superwettability. Prof. Lei Jiang has discovered and established the basic principle of the interfacial material systems with superwettability and extended them to successful innovative applications. His work has been followed by more than 1,400 research institutions in 94 countries around the world. He is the most original and influential scientist in the field of material science in China.
    He has built the interfacial material systems with superwettability and further extend this system to interfacial chemistry. His work pioneers the development of this field, and many of his fundamental technologies have been transferred to practical products in the market.
    Due to his contribution to the development of superwettability, he won the “TWAS Prize in Chemistry” in 2011, the Advanced Science and Technology Award of “THE HO LEUNG HO LEE FUNDATION” in 2013 and the “Outstanding Achievement Award” of the Chinese Academy of Sciences in 2014. In 2016, he won the “UNESCO Medals” for contributions to the development of nanoscience and nanotechnologies, and the “Nikkei Asia Prize”. In 2017, he won the “Humboldt Research Award” in Germany. In 2018, he was awarded the “Qiu Shi Outstanding Scientist Award” and “Nano Research Award”. In 2020, he won the “ACS Nano Lectureship Award”. In 2022, he won Tan Kah Kee Science Award.
    Dr Lei Jiang is a Professor at Technical Institute of Physics and Chemistry, Chinese Academy of Sciences (TIPC) and University of Technology Sydney (UTS). He is an academician of the Chinese Academy of Sciences, Academy of Sciences for the Developing World, National Academy of Engineering (USA), Australian Academy of Science and Academia Europaea.
    Lei received his Bachelor’s and Master’s degrees from Jilin University, and PhD from the University of Tokyo. He worked as a post-doctoral fellow with Prof. Akira Fujishima and then as a senior researcher in the Kanagawa Academy of Sciences and Technology. In 1999, he joined Institute of Chemistry, Chinese Academy of Sciences. In 2015, he and his group moved to TIPC. He joined UTS in 2023 as a part-time professor.
    His scientific interests focus on bio-inspired, smart, multi-scale interfacial materials with superwettability. Prof. Lei Jiang has discovered and established the basic principle of the interfacial material systems with superwettability and extended them to successful innovative applications. His work has been followed by more than 1,400 research institutions in 94 countries around the world. He is the most original and influential scientist in the field of material science in China.
    He has built the interfacial material systems with superwettability and further extend this system to interfacial chemistry. His work pioneers the development of this field, and many of his fundamental technologies have been transferred to practical products in the market.
    Due to his contribution to the development of superwettability, he won the “TWAS Prize in Chemistry” in 2011, the Advanced Science and Technology Award of “THE HO LEUNG HO LEE FUNDATION” in 2013 and the “Outstanding Achievement Award” of the Chinese Academy of Sciences in 2014. In 2016, he won the “UNESCO Medals” for contributions to the development of nanoscience and nanotechnologies, and the “Nikkei Asia Prize”. In 2017, he won the “Humboldt Research Award” in Germany. In 2018, he was awarded the “Qiu Shi Outstanding Scientist Award” and “Nano Research Award”. In 2020, he won the “ACS Nano Lectureship Award”. In 2022, he won Tan Kah Kee Science Award.
    • Academic
  • Director
    Contact
    • Laureate Fellow
    • Physics Discipline
    • Laureate FellowPhysics Discipline
    Dayong Jin is a Clarivate Highly Cited Researcher, one of the world’s top 0.1% influential researchers across multiple fields. He has spent the past decade driving the transformation of photonics and materials into analytical, diagnostic and imaging devices for disease detection, including cancer. These devices use photonics technologies to analyse saliva, urine or blood to identify early signs of disease and toxins.

    His research has been in the physical, engineering and interdisciplinary sciences, with expertise in optics engineering, automation devices, luminescent materials, microscopy imaging, and analytical chemistry, to enable rapid detection of cells and molecules.

    More recently, Dayong has worked to develop rapid COVID-19 spike-protein tests that allow virus detection from asymptomatic patients. These tests deliver quick results at a reduced cost.

    This technology builds upon his “Super Dots”, a new family of nanophotonic probes that can up-convert infrared photons into intense visible light at the nanoscale. Several fascinating properties have been discovered since to allow high-throughput bio-discoveries, data storage and high-security-level anti-counterfeiting applications, setting records for the tracking of single-molecule transport, super-resolution microscopy, nanoscale thermometry, and recently optical tweezers.

    Dayong obtained his PhD from Macquarie University in 2007. At Macquarie, he was promoted to Lecturer in 2010, Senior Lecturer in 2013, Associate Professor in 2014 and Professorial Fellow in 2015.

    He joined UTS in 2015, as a Chair Professor, to lead its research in Materials and Technology and to establish the Institute for Biomedical Materials and Devices (IBMD), of which he is the director.

    IBMD leverages multi-disciplinary sciences in instrumental physics, materials science, photonics, nanotechnology, molecular biology and engineering to develop a range of research capabilities, and new technology solutions in the areas of cancer, neuron, pathogen, point-of-care testing, wearable and implantable biomaterials and devices.

    Dayong also established the Australian Research Council Industry Transformation Research Hub for Integrated Devices for End-user Analysis at Low Levels (ARC IDEAL Research Hub), the Department of Industry, Science, Energy and Resources’ Australia-China Joint Research Centre for Point of Care Testing (DISER POCT) and recently the UTS-SUSTech Joint Research Centre for Biomedical Materials & Devices. He has also been Chair Professor at Southern University of Science and Technology since 2019.

    He has won the Australian Museum Eureka Prize (2015), the Australian Academy of Science engineering science medal (2017), the Australian Prime Minister Prize for Science – Physical Scientist of the Year (2017), and the Australian Research Council Laureate Fellowship (2021). He is a fellow of Australian Academy of Technology and Engineering.
    Dayong Jin is a Clarivate Highly Cited Researcher, one of the world’s top 0.1% influential researchers across multiple fields. He has spent the past decade driving the transformation of photonics and materials into analytical, diagnostic and imaging devices for disease detection, including cancer. These devices use photonics technologies to analyse saliva, urine or blood to identify early signs of disease and toxins.

    His research has been in the physical, engineering and interdisciplinary sciences, with expertise in optics engineering, automation devices, luminescent materials, microscopy imaging, and analytical chemistry, to enable rapid detection of cells and molecules.

    More recently, Dayong has worked to develop rapid COVID-19 spike-protein tests that allow virus detection from asymptomatic patients. These tests deliver quick results at a reduced cost.

    This technology builds upon his “Super Dots”, a new family of nanophotonic probes that can up-convert infrared photons into intense visible light at the nanoscale. Several fascinating properties have been discovered since to allow high-throughput bio-discoveries, data storage and high-security-level anti-counterfeiting applications, setting records for the tracking of single-molecule transport, super-resolution microscopy, nanoscale thermometry, and recently optical tweezers.

    Dayong obtained his PhD from Macquarie University in 2007. At Macquarie, he was promoted to Lecturer in 2010, Senior Lecturer in 2013, Associate Professor in 2014 and Professorial Fellow in 2015.

    He joined UTS in 2015, as a Chair Professor, to lead its research in Materials and Technology and to establish the Institute for Biomedical Materials and Devices (IBMD), of which he is the director.

    IBMD leverages multi-disciplinary sciences in instrumental physics, materials science, photonics, nanotechnology, molecular biology and engineering to develop a range of research capabilities, and new technology solutions in the areas of cancer, neuron, pathogen, point-of-care testing, wearable and implantable biomaterials and devices.

    Dayong also established the Australian Research Council Industry Transformation Research Hub for Integrated Devices for End-user Analysis at Low Levels (ARC IDEAL Research Hub), the Department of Industry, Science, Energy and Resources’ Australia-China Joint Research Centre for Point of Care Testing (DISER POCT) and recently the UTS-SUSTech Joint Research Centre for Biomedical Materials & Devices. He has also been Chair Professor at Southern University of Science and Technology since 2019.

    He has won the Australian Museum Eureka Prize (2015), the Australian Academy of Science engineering science medal (2017), the Australian Prime Minister Prize for Science – Physical Scientist of the Year (2017), and the Australian Research Council Laureate Fellowship (2021). He is a fellow of Australian Academy of Technology and Engineering.
    • 3 Good Health and Well Being
    • Academic
    • Masters Research or PhD student supervision
    Disciplines
    • Analytical chemistry
    • Medical biotechnology
    • Biomedical engineering
    • Atomic, molecular and optical physics
    • Industrial biotechnology
    • Nanotechnology
    • Physical chemistry
    • Professor
    • Physics Discipline
    • ProfessorPhysics Discipline

    Dr Irina Kabakova is a Professor in Optical Physics with the School of Mathematical and Physical Sciences, UTS. She specialises in developing novel microscopy techniques based on Brillouin light scattering that can be directly applied to map local compressibility and viscoelasticity of cells and tissues at the microscale. She also has interests in photonic integration and miniaturisation of imaging setups that will enable translation of laboratory techniques towards clinical use. 

    Irina is an alumna of Moscow State University (2004-2007), where she did her Masters Degree in nonlinear optics, and the University of Sydney (2008-2011) where she undertook her PhD in nonlinear optics, high-Q cavities and all-optical switching. Irina held various research positions at the University of Sydney, Nanoscience Centre AMOLF in Amsterdam, and Imperial College London before moving to UTS in 2017.

    In 2018, Irina received a prestigious Australian Research Council Discovery award to construct the first in Australia Brillouin Imaging (BI) Facility and study application of BI to understanding mechanobiology of bone and lung cells. This research aims to explain how pathological processes within these biological systems alter their micromechanical properties and apply BI as a diagnostics tool for various human diseases and conditions.

    As a dedicated educator, Irina has contributed to the development of several teaching programs for UTS’s Bachelor of Science in Physics degree (Optics, Medical Devices and Diagnostics, Medical Imaging Technology). She is a core member of the Institute of Biomedical Materials and Devices (IBMD@UTS). To date, she has attracted a combined total of over $70m in research funding – a major achievement in a relatively short scientific career. She is a Chief Investigator in the Australian Research Council Centers of Excellence in Quantum Biotechnology (QUBIC) and Optical Microcombs for Breakthrough Science (COMBS).

    In 2022, Irina received the Australian and New Zealand Optical Society (ANZOS) Award for Mid-Career Scientists and the Mid-Career Researcher Award from UTS in 2023. She has published widely in top tier journals and books including Nature Methods, Nature Communications, Small and Biofabrication. She has also been a keynote, plenary and invited speaker at conferences in Australia, Europe and USA.

    Fascinated by her field of research, Irina’s ultimate aim is to increase the speed and bring down the cost of these promising new technologies so they can be used in the diagnostics and treatment of many diseases including cancer, osteoporosis, osteoarthritis and fibrosis.

     

    For further details see research group website Kabakova Lab UTS

    Dr Irina Kabakova is a Professor in Optical Physics with the School of Mathematical and Physical Sciences, UTS. She specialises in developing novel microscopy techniques based on Brillouin light scattering that can be directly applied to map local compressibility and viscoelasticity of cells and tissues at the microscale. She also has interests in photonic integration and miniaturisation of imaging setups that will enable translation of laboratory techniques towards clinical use. 

    Irina is an alumna of Moscow State University (2004-2007), where she did her Masters Degree in nonlinear optics, and the University of Sydney (2008-2011) where she undertook her PhD in nonlinear optics, high-Q cavities and all-optical switching. Irina held various research positions at the University of Sydney, Nanoscience Centre AMOLF in Amsterdam, and Imperial College London before moving to UTS in 2017.

    In 2018, Irina received a prestigious Australian Research Council Discovery award to construct the first in Australia Brillouin Imaging (BI) Facility and study application of BI to understanding mechanobiology of bone and lung cells. This research aims to explain how pathological processes within these biological systems alter their micromechanical properties and apply BI as a diagnostics tool for various human diseases and conditions.

    As a dedicated educator, Irina has contributed to the development of several teaching programs for UTS’s Bachelor of Science in Physics degree (Optics, Medical Devices and Diagnostics, Medical Imaging Technology). She is a core member of the Institute of Biomedical Materials and Devices (IBMD@UTS). To date, she has attracted a combined total of over $70m in research funding – a major achievement in a relatively short scientific career. She is a Chief Investigator in the Australian Research Council Centers of Excellence in Quantum Biotechnology (QUBIC) and Optical Microcombs for Breakthrough Science (COMBS).

    In 2022, Irina received the Australian and New Zealand Optical Society (ANZOS) Award for Mid-Career Scientists and the Mid-Career Researcher Award from UTS in 2023. She has published widely in top tier journals and books including Nature Methods, Nature Communications, Small and Biofabrication. She has also been a keynote, plenary and invited speaker at conferences in Australia, Europe and USA.

    Fascinated by her field of research, Irina’s ultimate aim is to increase the speed and bring down the cost of these promising new technologies so they can be used in the diagnostics and treatment of many diseases including cancer, osteoporosis, osteoarthritis and fibrosis.

     

    For further details see research group website Kabakova Lab UTS

    • 3 Good Health and Well Being
    • 7 Affordable and Clean Energy
    • Academic
    • Masters Research or PhD student supervision
    Disciplines
    • Atomic, molecular and optical physics
    • Condensed matter physics
    • Other biomedical and clinical sciences
    • Nonlinear optics and spectroscopy
    • Casual Academic
    • Faculty of Science
    • Casual AcademicFaculty of Science

    Dr. Jawairia Khan (Jia) is a materials scientist with a background in Textile Engineering. She was awarded her PhD from the University of Wollongong, at the intersection of Analytical Chemistry and Materials Science. She brings deep expertise in advanced nanotechnology and the development of functional materials. Dr. Khan’s research focuses on designing functional fibers and nanophotonic probes as high-performance bioanalytical tools, with a strong emphasis on translating these innovations into wearable sensing technologies. Her recent work includes the development of low-cost, fiber-based microfluidic platforms for point-of-care diagnostics, enabling electrophoretic separations and on-fiber analyte detection. Currently, she is advancing highly sensitive fiber electronic sensors and integrating them into next-generation multimodal wearable systems, leveraging the unique capabilities of upconversion nanoprobes and flexible textile substrates. Dr. Khan has a diverse professional background spanning both academia and industry, driving interdisciplinary innovation in wearable biosensing and next-generation healthcare technologies.

    Dr. Jawairia Khan (Jia) is a materials scientist with a background in Textile Engineering. She was awarded her PhD from the University of Wollongong, at the intersection of Analytical Chemistry and Materials Science. She brings deep expertise in advanced nanotechnology and the development of functional materials. Dr. Khan’s research focuses on designing functional fibers and nanophotonic probes as high-performance bioanalytical tools, with a strong emphasis on translating these innovations into wearable sensing technologies. Her recent work includes the development of low-cost, fiber-based microfluidic platforms for point-of-care diagnostics, enabling electrophoretic separations and on-fiber analyte detection. Currently, she is advancing highly sensitive fiber electronic sensors and integrating them into next-generation multimodal wearable systems, leveraging the unique capabilities of upconversion nanoprobes and flexible textile substrates. Dr. Khan has a diverse professional background spanning both academia and industry, driving interdisciplinary innovation in wearable biosensing and next-generation healthcare technologies.

    • 3 Good Health and Well Being
    • 10 Reduced Inequalities
    • 17 Partnerships for the Goals
    • 16 Peace, Justice and Strong Institutions
    • Academic
    • Masters Research or PhD student supervision
    • Industry Projects
    • Collaborative projects
    • Join a web conference as a panellist or speaker
    • Membership of an advisory committee
    Disciplines
    • Microfluidics and nanofluidics
    • Nanophotonics
    • Medical biotechnology diagnostics (incl. biosensors)
    • Chancellor's Research Fellow
    • Physics Discipline
    • Chancellor's Research FellowPhysics Discipline

    I am an NHMRC Emerging Leadership Fellow (EL1), UTS Chancellor’s Research Fellow (CRF), and Senior Lecturer in the School of Mathematical and Physical Sciences at the University of Technology Sydney (UTS), as well as a core member of the Institute for Biomedical Materials and Devices (IBMD). My research spans multiple scientific disciplines, including materials science, optical physics, and nanotechnology, with a focus on developing advanced nanophotonic, imaging, and detection technologies.

    I investigate fundamental photophysical phenomena and their underlying mechanisms to create next-generation bioanalytical tools. These tools are designed to diagnose diseases at the molecular level by using nanoscopic probes to detect biomarkers at early stages, thereby addressing critical health challenges through enhanced accuracy and accessibility in diagnostics. I have led pioneering work in materials science and nanophotonics, thoroughly characterizing their properties and applying these innovations in imaging and analytical immunoassays for diverse biomedical applications.

    A. Selected Research Topics

    1) Advanced Nanophotonics and Imaging Technologies
    My research delves into fundamental photophysical phenomena to advance nanophotonic and imaging technologies. A key focus is on exploring and applying the properties of photonic materials for bioimaging and detection.
    I developed a method for nanoscale tuning of upconversion nanoparticles (UCNPs), establishing a comprehensive library of luminescent nanoprobes. This enables super-capacity multiplexed detection of single molecules beyond the diffraction limit, revolutionizing high-throughput digital assays.
    In parallel, I designed imaging instruments and AI algorithms for multiplexed detection of pathogenic molecule. This work integrates deep learning to classify the optical fingerprints of nanoparticles, advancing the field of optical multiplexing.
    I also developed fully photostimulated reversible photochromic materials with tunable dual-mode luminescence and high repeatability. My studies identified ionic valence transformation, metal nanoclusters, and defect states as key mechanisms, supporting applications in multidimensional optical data storage, information encryption, and NIR imaging. I further integrated X-ray-induced photochromism with photoluminescence for multimodal anti-counterfeiting and 3D X-ray imaging. This work was featured by the American Chemical Society press.
    My research also revealed tunable energy transfer pathways and nonlinear spectral responses in UCNPs under varying excitation power, enabling super-resolution imaging and long-term tracking.
    I established protocols for polymer-coated nanoprobes to enhance biocompatibility and surface functionality, facilitating high-precision single-molecule assays and multiplexed biomarker detection.
    These innovations have been recognized by the 2025 Vice-Chancellor’s Award for Research Excellence and the NSW Premier’s Prize for Science & Engineering (Physical Sciences).
    2) UCNP Strip Test for COVID-19
    I led the development of a UCNP-based rapid antigen test in collaboration with Alcolizer Technology, described as a “game-changer” by the media (9News, 16.12.2021). Supported by the Innovative Manufacturing CRC (2020–2022, co-CI) and the UTS Chancellor’s Fellowship (2022–2026, Lead CI), the test detects SARS-CoV-2 within five minutes with over 1,000× greater sensitivity than commercial antigen kits.
    The work has been featured by SBS (07.11.2024), the NSW Government (31.03.2025), NHMRC (16.03.2024), and 7News, among others. It won the 2022 KCA Best Research Commercialisation Award. I also received the 2025 Discovery Award (Highly Commended, Australian Health and Medical Research Awards), 2023 NHMRC Research Excellence Award, 2023 Dean’s Award for Science & Collaboration, and the 2021 ARC Research Hub Commercialisation Award.
    3) Placental Insufficiency Biomarker Strip Test (SPINT1)
    As lead investigator, I supervised a postdoctoral researcher and led the clinical translation of a nanoparticle-based SPINT1 strip test for detecting placental insufficiency. In collaboration with Mercy Hospital for Women and the University of Melbourne, the test achieved a tenfold improvement in sensitivity compared to existing methods.
    4) Cancer Diagnostics
    I am leveraging nanotechnology to develop next-generation diagnostic tools. My nanoprobe technologies are central to the ARC IDEAL Research Hub. Between 2020–2022, I led translational projects on single-molecule assays and collaborated with three Australian SMEs.
    In partnership with Minomic International Ltd, I developed single-molecule antigen biomarker assays and a low-cost diagnostic device. I also collaborated with SpeeDX, supported by DISER, to create single-molecule oligo assays. In 2021, through the Australia–China Joint Research Centre for Point-of-Care Testing, I led a project funded by the Australian Government to develop an ultrasensitive multiplexed assay for five single-stranded DNAs (US patent/18040513), in collaboration with SpeeDX.

    B. Prizes, Honours and Awards

    2025    RSNSW Bicentennial Early Career Research and Service Citations, The Royal Society of New South Wales

    2025    Vice-Chancellor’s Awards for Research Excellence (Early Career Research Excellence Award)

    2024    NSW Premier's Prizes for Science & Engineering (Early Career Researcher of the Year-Physical Sciences)
    2024    Australian Health and Medical Research Awards - Discovery Award Highly Recommended
    2024    Finalist of UTS Vice-Chancellor’s Awards - 2023 Early Career Research Excellence Award, UTS

    2024    Shortlisted for L'Oréal-UNESCO Australia & New Zealand for Women in Science Fellowship

    2024    Selected for the 2024 Franklin Women Inclusive Leadership Mentoring Program

    2023    NHMRC 2023 Research Excellence Awards - NHMRC Bernie Banton Investigator Grant Award (recognising the highest-ranked applicant in 2023 Investigator Grants Emerging Leadership Scheme)
    2023    Dean's Award for Science & Collaboration, UTS
    2023    MAPS Awards for Research Excellence - Early Career Researchers of the Year, UTS
    2023    Commercialisation Award, UTS
    2021    Dean's Awards 2021, Highly Commended 'External Impact', UTS
    2019    UTS Vice Chancellor’s Research Student Conference Fund
    2016    UTS Top-Up Scholarship
    2015    Outstanding Master’s Thesis
    2014    The Graduate National Scholarship (highest-ranked applicant)

    2014    Special Recognition Award (highest-ranked applicant)

    2014    Scholarship of Wu Da Guan (highest-ranked applicant)
    2013    The Excellent Graduate Student
    2012    The Excellent Bachelor’s Thesis / Municipal Merit Student
    C. Selected Grants Support  

    2026 WUN Research Development Fund (CI)

    2025 Industry collaboration project (Lead CI)

    2025 CRC SAAFE Kickstart Project (CI)

    2025 MCR Research Capabilities Development Initiative (Lead CI)

    2025 Faculty of Science Seed Funding (Lead CI)

    2024 Collaboration Project with University of Melbourne (UoM) (Lead CI)
    2023 Collaboration Project with UoM (Lead CI)
    2023 NHMRC Emerging Leadership Level 1 Fellowship (Highest ranking) (Lead CI)
    2023 Faculty of Science Seed Funding (Lead CI)
    2023 The iCare Grant, Dust Diseases Board (co CI)
    2022 Chancellor's Research Fellowship (Lead CI) 
    2021 CRB Development Funds (Lead CI)
    2020 Innovative Manufacturing Cooperative Research Centre Fund (co CI)
    2019 Vice Chancellor’s Research Student Conference Fund (Lead CI)
    D. Selected Professional Activities and Services 
    (1) Journal Editorial Services
      - Member of the Youth Editorial Board of Exploration
      - Editorial Board Member for Scientific Reports
      - Guest editor of Nanomaterials
      - Member of Editorial Board of Journal of Biomaterials
      - Youth Editorial Board of View
      - Editorial Board Member of Journal of Optics and Photonics Research 
      - Review Editor on the Editorial Board of Frontiers in Chemistry
      - Guest Editor of JoVE
    (2) Journal Review (>2 per month): 
    Chemical Society Reviews, Matter, Science Advances, Advanced Materials, JACS, ACS Nano, Nano Energy, Nano Letters, Advanced Functional Materials, Chemical Engineering Journal, Journal of Nanobiotechnology, Chemical Engineering Journal, Biointerfaces, Bioconjugate Chemistry, Environmental Pollution, Scientific Reports, Frontiers in Oncology, Journal of Luminescence, Bioactive Materials, Ceramics International, et al.
    (3) UTS Services
      - Member of the Research Professional Development Advisory Committee 
      - Member of the Faculty Research Degrees Committee
      - HDR Panel

    I am an NHMRC Emerging Leadership Fellow (EL1), UTS Chancellor’s Research Fellow (CRF), and Senior Lecturer in the School of Mathematical and Physical Sciences at the University of Technology Sydney (UTS), as well as a core member of the Institute for Biomedical Materials and Devices (IBMD). My research spans multiple scientific disciplines, including materials science, optical physics, and nanotechnology, with a focus on developing advanced nanophotonic, imaging, and detection technologies.

    I investigate fundamental photophysical phenomena and their underlying mechanisms to create next-generation bioanalytical tools. These tools are designed to diagnose diseases at the molecular level by using nanoscopic probes to detect biomarkers at early stages, thereby addressing critical health challenges through enhanced accuracy and accessibility in diagnostics. I have led pioneering work in materials science and nanophotonics, thoroughly characterizing their properties and applying these innovations in imaging and analytical immunoassays for diverse biomedical applications.

    A. Selected Research Topics

    1) Advanced Nanophotonics and Imaging Technologies
    My research delves into fundamental photophysical phenomena to advance nanophotonic and imaging technologies. A key focus is on exploring and applying the properties of photonic materials for bioimaging and detection.
    I developed a method for nanoscale tuning of upconversion nanoparticles (UCNPs), establishing a comprehensive library of luminescent nanoprobes. This enables super-capacity multiplexed detection of single molecules beyond the diffraction limit, revolutionizing high-throughput digital assays.
    In parallel, I designed imaging instruments and AI algorithms for multiplexed detection of pathogenic molecule. This work integrates deep learning to classify the optical fingerprints of nanoparticles, advancing the field of optical multiplexing.
    I also developed fully photostimulated reversible photochromic materials with tunable dual-mode luminescence and high repeatability. My studies identified ionic valence transformation, metal nanoclusters, and defect states as key mechanisms, supporting applications in multidimensional optical data storage, information encryption, and NIR imaging. I further integrated X-ray-induced photochromism with photoluminescence for multimodal anti-counterfeiting and 3D X-ray imaging. This work was featured by the American Chemical Society press.
    My research also revealed tunable energy transfer pathways and nonlinear spectral responses in UCNPs under varying excitation power, enabling super-resolution imaging and long-term tracking.
    I established protocols for polymer-coated nanoprobes to enhance biocompatibility and surface functionality, facilitating high-precision single-molecule assays and multiplexed biomarker detection.
    These innovations have been recognized by the 2025 Vice-Chancellor’s Award for Research Excellence and the NSW Premier’s Prize for Science & Engineering (Physical Sciences).
    2) UCNP Strip Test for COVID-19
    I led the development of a UCNP-based rapid antigen test in collaboration with Alcolizer Technology, described as a “game-changer” by the media (9News, 16.12.2021). Supported by the Innovative Manufacturing CRC (2020–2022, co-CI) and the UTS Chancellor’s Fellowship (2022–2026, Lead CI), the test detects SARS-CoV-2 within five minutes with over 1,000× greater sensitivity than commercial antigen kits.
    The work has been featured by SBS (07.11.2024), the NSW Government (31.03.2025), NHMRC (16.03.2024), and 7News, among others. It won the 2022 KCA Best Research Commercialisation Award. I also received the 2025 Discovery Award (Highly Commended, Australian Health and Medical Research Awards), 2023 NHMRC Research Excellence Award, 2023 Dean’s Award for Science & Collaboration, and the 2021 ARC Research Hub Commercialisation Award.
    3) Placental Insufficiency Biomarker Strip Test (SPINT1)
    As lead investigator, I supervised a postdoctoral researcher and led the clinical translation of a nanoparticle-based SPINT1 strip test for detecting placental insufficiency. In collaboration with Mercy Hospital for Women and the University of Melbourne, the test achieved a tenfold improvement in sensitivity compared to existing methods.
    4) Cancer Diagnostics
    I am leveraging nanotechnology to develop next-generation diagnostic tools. My nanoprobe technologies are central to the ARC IDEAL Research Hub. Between 2020–2022, I led translational projects on single-molecule assays and collaborated with three Australian SMEs.
    In partnership with Minomic International Ltd, I developed single-molecule antigen biomarker assays and a low-cost diagnostic device. I also collaborated with SpeeDX, supported by DISER, to create single-molecule oligo assays. In 2021, through the Australia–China Joint Research Centre for Point-of-Care Testing, I led a project funded by the Australian Government to develop an ultrasensitive multiplexed assay for five single-stranded DNAs (US patent/18040513), in collaboration with SpeeDX.

    B. Prizes, Honours and Awards

    2025    RSNSW Bicentennial Early Career Research and Service Citations, The Royal Society of New South Wales

    2025    Vice-Chancellor’s Awards for Research Excellence (Early Career Research Excellence Award)

    2024    NSW Premier's Prizes for Science & Engineering (Early Career Researcher of the Year-Physical Sciences)
    2024    Australian Health and Medical Research Awards - Discovery Award Highly Recommended
    2024    Finalist of UTS Vice-Chancellor’s Awards - 2023 Early Career Research Excellence Award, UTS

    2024    Shortlisted for L'Oréal-UNESCO Australia & New Zealand for Women in Science Fellowship

    2024    Selected for the 2024 Franklin Women Inclusive Leadership Mentoring Program

    2023    NHMRC 2023 Research Excellence Awards - NHMRC Bernie Banton Investigator Grant Award (recognising the highest-ranked applicant in 2023 Investigator Grants Emerging Leadership Scheme)
    2023    Dean's Award for Science & Collaboration, UTS
    2023    MAPS Awards for Research Excellence - Early Career Researchers of the Year, UTS
    2023    Commercialisation Award, UTS
    2021    Dean's Awards 2021, Highly Commended 'External Impact', UTS
    2019    UTS Vice Chancellor’s Research Student Conference Fund
    2016    UTS Top-Up Scholarship
    2015    Outstanding Master’s Thesis
    2014    The Graduate National Scholarship (highest-ranked applicant)

    2014    Special Recognition Award (highest-ranked applicant)

    2014    Scholarship of Wu Da Guan (highest-ranked applicant)
    2013    The Excellent Graduate Student
    2012    The Excellent Bachelor’s Thesis / Municipal Merit Student
    C. Selected Grants Support  

    2026 WUN Research Development Fund (CI)

    2025 Industry collaboration project (Lead CI)

    2025 CRC SAAFE Kickstart Project (CI)

    2025 MCR Research Capabilities Development Initiative (Lead CI)

    2025 Faculty of Science Seed Funding (Lead CI)

    2024 Collaboration Project with University of Melbourne (UoM) (Lead CI)
    2023 Collaboration Project with UoM (Lead CI)
    2023 NHMRC Emerging Leadership Level 1 Fellowship (Highest ranking) (Lead CI)
    2023 Faculty of Science Seed Funding (Lead CI)
    2023 The iCare Grant, Dust Diseases Board (co CI)
    2022 Chancellor's Research Fellowship (Lead CI) 
    2021 CRB Development Funds (Lead CI)
    2020 Innovative Manufacturing Cooperative Research Centre Fund (co CI)
    2019 Vice Chancellor’s Research Student Conference Fund (Lead CI)
    D. Selected Professional Activities and Services 
    (1) Journal Editorial Services
      - Member of the Youth Editorial Board of Exploration
      - Editorial Board Member for Scientific Reports
      - Guest editor of Nanomaterials
      - Member of Editorial Board of Journal of Biomaterials
      - Youth Editorial Board of View
      - Editorial Board Member of Journal of Optics and Photonics Research 
      - Review Editor on the Editorial Board of Frontiers in Chemistry
      - Guest Editor of JoVE
    (2) Journal Review (>2 per month): 
    Chemical Society Reviews, Matter, Science Advances, Advanced Materials, JACS, ACS Nano, Nano Energy, Nano Letters, Advanced Functional Materials, Chemical Engineering Journal, Journal of Nanobiotechnology, Chemical Engineering Journal, Biointerfaces, Bioconjugate Chemistry, Environmental Pollution, Scientific Reports, Frontiers in Oncology, Journal of Luminescence, Bioactive Materials, Ceramics International, et al.
    (3) UTS Services
      - Member of the Research Professional Development Advisory Committee 
      - Member of the Faculty Research Degrees Committee
      - HDR Panel

    • Academic
    • Masters Research or PhD student supervision
    • Collaborative projects
    • Industry Projects
    • Join a web conference as a panellist or speaker
    • Mentoring (long-term)
    Disciplines
    • Analytical chemistry
    • Atomic, molecular and optical physics
    • Optical properties of materials
    • Associate Professor
    • Physics Discipline
    • Associate ProfessorPhysics Discipline

    Gungun Lin is an Associate Professor at the School of Mathematical and Physical Sciences, UTS. He is a core member of the Institute for Biomedical Materials and Devices (IBMD). Prior to joining UTS, Gungun received his Master of Science Degree from the University of Ulm in Germany and his PhD degree with the highest honor (Summa Cum Laude) from Chemnitz University of Technology in Germany in 2016. He then received an NHMRC Early Career Fellowship and an ARC DECRA fellowship to establish his research group. He was promoted to Senior Lecturer in 2022 and Associate Professor in 2026.

     

    Gungun leads a research group of "Intelligent Bio-MEMS" focusing on both fundamental and applied aspects of biosensing, microfluidics and lab-on-a-chip technologies. His work includes the design, fabrication, and characterization of smart, small-scale sensors, actuators and robots and their integration with microfluidic systems for biomedical applications. He specializes in studying the magneto-electrical properties and magneto-mechanics of functional micro- and nanostructures for sensing, acutation and robotic applications, and investigates how these systems dynamically interact with complex environments, including fluidic flows. Gungun's research has been published in prominent journals and has attracted over $8M in national competative funding.

     

    Honors and awards:

    2026 ARC Future Fellowship, Australian Research Council

    2026 NHMRC Emerging Leadership Level-2 Investigator, NHMRC
    2024 Vice Chancellor's Award for Research Excellence through Collaboration or Partnership, UTS
    2023 Dean's Award for Science & Collaboration, Faculty of Science, UTS
    2023 Supervision and Mentoring Award, ARC IDEAL Research Translation Hub
    2023 Science and Technology Award, ARC IDEAL Research Translation Hub
    2022 ARC Discovery Early Career Researcher Award, Australian Research Council
    2021 Marylou Ingram Scholar, International Society for Advancement of Cytometry
    2019 NHMRC Peter Doherty Biomedical Engineering Fellowship, NHMRC
    2018 Rising Star Award, Association of Australian Chinese Biomedical Scientists, Australia
    2017 the Ehrenfried Walther von Tschirnhaus Medal, Leibniz IFW Dresden, Germany
    2016 Summa Cum Laude (of highest honour) for PhD thesis, Chemnitz University of Technology, Germany
    2015 Chinese Government Award for Outstanding Students Abroad (Top 1%), Ministry of Education China
    2009 Baden-württemberg Scholarship, Baden-württemberg Stiftung, Germany
    2008 He Yaoguang Prize (Top 1%), Southeast University Education Foundation
    2008 Student Research Training Project (SRTP) Excellence Award, Southeast University, China
    2006 President Scholarship (Top 1%), Southeast University, China

    Selected grants:

    2027-2032 NHMRC EL2 Investigator Grant (Lead CI)

    2027-2030 ARC Future Fellowship (Lead CI)

    2025-2028 ARC Discovery Project (Lead CI)

    2025-2028 NSW Non-animal Technologies Network Grant (CI)

    2025 UTS Cross Faculty Collaboration Scheme (Co CI)

    2024 Hamilton Syringe Grant (Lead CI)

    2023-2025 ARC Discovery Early Career Researcher Award (Lead CI)
    2022 UTS CRB Grant Development Fund (Lead CI)
    2021 Faculty of Science Seed Funding (Lead CI)
    2021-2023 Australia-China Joint Research Centre for Point-of-care Testing (Co CI)
    2020-2024 ARC Research Hub for Integrated Devices for End-user Analysis at Low levels (Co CI)
    2019-2022 NHMRC Early Career Fellowship (Lead CI)
    2018 Faculty of Science Staff Travel Fund (Lead CI)

    Teaching activities:

    • 91705 Medical Devices & Diagnostics - Subject coordinator & Lecturer

    • 60101 Chemistry and Materials Science - Subject coordinator

    • 68075 Advanced Materials - Demonstrator
    • 68037 Physical modelling - Demonstrator
    • 42721 Introduction to Biomedical Engineering - Lecturer

    Group members:

    • Mr Weihong Liang (PhD candidate, 2024 - present, joint supervision: Guochen Bao)

    • Ms Asmae Mihandoust (PhD candidate, 2025 - present, joint supervision: Dayong Jin)

    • Mr Mahdi Aliverdinia (PhD candidate, 2026 - present, join supervision: Guochen Bao)

    • Mr Ethan Marsland (Research Masters, 2026 - present, join supervision: Ying Zhu)

    • Mr Zelyu Chen (Postdoctoral research associate)

    • Mr Vahid Yaghoubi Naei (Postdoctoral research associate)

    • Ms Jawairia Khan (Visiting scholar)

    • Mr Majid Alizadeh (Visiting scholar)

    Alumni:

    • Dr Yuan Liu (Associate professor at Chinese Academics of Science, former PhD student, Joint supervision: Dayong Jin)

    • Dr Guocheng Fang (Cancer Institute EC Fellow at UTS, former PhD student, Joint supervision: Dayong Jin, Hongxu Lu)

    • Dr Guan Huang (Research fellow at Harvard Medical School, former PhD student, joint supervision: Dayong Jin, Ying Zhu)

    • Dr Wei Ren (Associate professor at Shanxi Normal University China, former PhD student,  joint supervision: Dayong Jin)

    • Dr Zhichao Yang (former PhD student, Joint supervision: Dayong Jin)

    • Dr Ming Lu (Technical officer at UTS, former PhD student, Joint supervision: Dayong Jin, Jiajia Zhou)

    • Dr Shen Zhang (Graduate sustainability engineer @ NettZero, former postdoctoral research associate)

    • Mr Milad Akhlaghi (DYJ fellowship student)

    • Mr Christian White (Master student, IMCRC scholarship, joint supervision: N. Rasick - SpeeDx)

    • Ms Sinead Dutkiewicz (Master student, Forensic Science, joint supervision: Martin Sadraeian)

    • Ms Kamalpreet Kaur (Master student, Forensic Science, joint supervision: Martin Sadraeian)

    • Mr Ethan Marsland (Honours student, joint supervision: Jawairia Khan)

    • Ms Maie Abdullah Alfadhel (Undergraduate, 60702 Science Internship)

    • Mr Singh Ajaypal (Undergraduate, 91820 Biosensors Internship)

    • Ms Qinghan Tang (Visiting scholar)

    • Mr Manaf Saidi (Visiting scholar, Mitacs Globalink Research Award)

    • A/Prof Kewu Li (Visiting scholar)

    • Ms Kehan Cai (Visiting scholar)

    Professional body roles and services:
    (1) Journal Review Activities
    • Nature Biomedical Engineering, Nature Communications, Advanced Materials, Advanced Functional Materials, ACS Nano, Lab on a Chip, and many more
    • Reviewer board member - Micromachines

    (2) Grant Assessment Activities
    • NHMRC Fellowship, Ideas, Development Grants Since 2019
    • ARC Fellowship, Discovery and Linkage Grants since 2020

    • Prostate Cancer UK

    (3) Professional Body Membership

    • NSW Non-Animal Technologies Network (NAT-net) Executive Comittee 

    • Australian Nanotechnology Network
    • International Society of Advancement of Cytometry

    (4) Journal Editorial Activities
    • Guest editor - Biosensors and Bioelectronics (Elsevier)
    • Topic editor - Journal of Applied Physics (AIP)

    (5) UTS and Faculty Services
    • Faculty of Science - Research Degrees Committee Member, since 2024

    • UTS & D+I Strategic Partnership Committe Member, since 2023

    • Manager of ARC "High-throughput portable and wearable device fabrication facility (LE180100043)", since 2019

    • UTS Physics Laboratory Upgrade Working Group - Academic lead and coordinator, 2022-2025

    Gungun Lin is an Associate Professor at the School of Mathematical and Physical Sciences, UTS. He is a core member of the Institute for Biomedical Materials and Devices (IBMD). Prior to joining UTS, Gungun received his Master of Science Degree from the University of Ulm in Germany and his PhD degree with the highest honor (Summa Cum Laude) from Chemnitz University of Technology in Germany in 2016. He then received an NHMRC Early Career Fellowship and an ARC DECRA fellowship to establish his research group. He was promoted to Senior Lecturer in 2022 and Associate Professor in 2026.

     

    Gungun leads a research group of "Intelligent Bio-MEMS" focusing on both fundamental and applied aspects of biosensing, microfluidics and lab-on-a-chip technologies. His work includes the design, fabrication, and characterization of smart, small-scale sensors, actuators and robots and their integration with microfluidic systems for biomedical applications. He specializes in studying the magneto-electrical properties and magneto-mechanics of functional micro- and nanostructures for sensing, acutation and robotic applications, and investigates how these systems dynamically interact with complex environments, including fluidic flows. Gungun's research has been published in prominent journals and has attracted over $8M in national competative funding.

     

    Honors and awards:

    2026 ARC Future Fellowship, Australian Research Council

    2026 NHMRC Emerging Leadership Level-2 Investigator, NHMRC
    2024 Vice Chancellor's Award for Research Excellence through Collaboration or Partnership, UTS
    2023 Dean's Award for Science & Collaboration, Faculty of Science, UTS
    2023 Supervision and Mentoring Award, ARC IDEAL Research Translation Hub
    2023 Science and Technology Award, ARC IDEAL Research Translation Hub
    2022 ARC Discovery Early Career Researcher Award, Australian Research Council
    2021 Marylou Ingram Scholar, International Society for Advancement of Cytometry
    2019 NHMRC Peter Doherty Biomedical Engineering Fellowship, NHMRC
    2018 Rising Star Award, Association of Australian Chinese Biomedical Scientists, Australia
    2017 the Ehrenfried Walther von Tschirnhaus Medal, Leibniz IFW Dresden, Germany
    2016 Summa Cum Laude (of highest honour) for PhD thesis, Chemnitz University of Technology, Germany
    2015 Chinese Government Award for Outstanding Students Abroad (Top 1%), Ministry of Education China
    2009 Baden-württemberg Scholarship, Baden-württemberg Stiftung, Germany
    2008 He Yaoguang Prize (Top 1%), Southeast University Education Foundation
    2008 Student Research Training Project (SRTP) Excellence Award, Southeast University, China
    2006 President Scholarship (Top 1%), Southeast University, China

    Selected grants:

    2027-2032 NHMRC EL2 Investigator Grant (Lead CI)

    2027-2030 ARC Future Fellowship (Lead CI)

    2025-2028 ARC Discovery Project (Lead CI)

    2025-2028 NSW Non-animal Technologies Network Grant (CI)

    2025 UTS Cross Faculty Collaboration Scheme (Co CI)

    2024 Hamilton Syringe Grant (Lead CI)

    2023-2025 ARC Discovery Early Career Researcher Award (Lead CI)
    2022 UTS CRB Grant Development Fund (Lead CI)
    2021 Faculty of Science Seed Funding (Lead CI)
    2021-2023 Australia-China Joint Research Centre for Point-of-care Testing (Co CI)
    2020-2024 ARC Research Hub for Integrated Devices for End-user Analysis at Low levels (Co CI)
    2019-2022 NHMRC Early Career Fellowship (Lead CI)
    2018 Faculty of Science Staff Travel Fund (Lead CI)

    Teaching activities:

    • 91705 Medical Devices & Diagnostics - Subject coordinator & Lecturer

    • 60101 Chemistry and Materials Science - Subject coordinator

    • 68075 Advanced Materials - Demonstrator
    • 68037 Physical modelling - Demonstrator
    • 42721 Introduction to Biomedical Engineering - Lecturer

    Group members:

    • Mr Weihong Liang (PhD candidate, 2024 - present, joint supervision: Guochen Bao)

    • Ms Asmae Mihandoust (PhD candidate, 2025 - present, joint supervision: Dayong Jin)

    • Mr Mahdi Aliverdinia (PhD candidate, 2026 - present, join supervision: Guochen Bao)

    • Mr Ethan Marsland (Research Masters, 2026 - present, join supervision: Ying Zhu)

    • Mr Zelyu Chen (Postdoctoral research associate)

    • Mr Vahid Yaghoubi Naei (Postdoctoral research associate)

    • Ms Jawairia Khan (Visiting scholar)

    • Mr Majid Alizadeh (Visiting scholar)

    Alumni:

    • Dr Yuan Liu (Associate professor at Chinese Academics of Science, former PhD student, Joint supervision: Dayong Jin)

    • Dr Guocheng Fang (Cancer Institute EC Fellow at UTS, former PhD student, Joint supervision: Dayong Jin, Hongxu Lu)

    • Dr Guan Huang (Research fellow at Harvard Medical School, former PhD student, joint supervision: Dayong Jin, Ying Zhu)

    • Dr Wei Ren (Associate professor at Shanxi Normal University China, former PhD student,  joint supervision: Dayong Jin)

    • Dr Zhichao Yang (former PhD student, Joint supervision: Dayong Jin)

    • Dr Ming Lu (Technical officer at UTS, former PhD student, Joint supervision: Dayong Jin, Jiajia Zhou)

    • Dr Shen Zhang (Graduate sustainability engineer @ NettZero, former postdoctoral research associate)

    • Mr Milad Akhlaghi (DYJ fellowship student)

    • Mr Christian White (Master student, IMCRC scholarship, joint supervision: N. Rasick - SpeeDx)

    • Ms Sinead Dutkiewicz (Master student, Forensic Science, joint supervision: Martin Sadraeian)

    • Ms Kamalpreet Kaur (Master student, Forensic Science, joint supervision: Martin Sadraeian)

    • Mr Ethan Marsland (Honours student, joint supervision: Jawairia Khan)

    • Ms Maie Abdullah Alfadhel (Undergraduate, 60702 Science Internship)

    • Mr Singh Ajaypal (Undergraduate, 91820 Biosensors Internship)

    • Ms Qinghan Tang (Visiting scholar)

    • Mr Manaf Saidi (Visiting scholar, Mitacs Globalink Research Award)

    • A/Prof Kewu Li (Visiting scholar)

    • Ms Kehan Cai (Visiting scholar)

    Professional body roles and services:
    (1) Journal Review Activities
    • Nature Biomedical Engineering, Nature Communications, Advanced Materials, Advanced Functional Materials, ACS Nano, Lab on a Chip, and many more
    • Reviewer board member - Micromachines

    (2) Grant Assessment Activities
    • NHMRC Fellowship, Ideas, Development Grants Since 2019
    • ARC Fellowship, Discovery and Linkage Grants since 2020

    • Prostate Cancer UK

    (3) Professional Body Membership

    • NSW Non-Animal Technologies Network (NAT-net) Executive Comittee 

    • Australian Nanotechnology Network
    • International Society of Advancement of Cytometry

    (4) Journal Editorial Activities
    • Guest editor - Biosensors and Bioelectronics (Elsevier)
    • Topic editor - Journal of Applied Physics (AIP)

    (5) UTS and Faculty Services
    • Faculty of Science - Research Degrees Committee Member, since 2024

    • UTS & D+I Strategic Partnership Committe Member, since 2023

    • Manager of ARC "High-throughput portable and wearable device fabrication facility (LE180100043)", since 2019

    • UTS Physics Laboratory Upgrade Working Group - Academic lead and coordinator, 2022-2025

    • 3 Good Health and Well Being
    • 4 Quality Education
    • 7 Affordable and Clean Energy
    • 9 Industry, Innovation and Infrastructure
    • Academic
    • Career advice
    • Collaborative projects
    • Masters Research or PhD student supervision
    • Mentoring (long-term)
    Disciplines
    • Micro- and nanosystems
    • Nanotechnology
    • Materials engineering
    • Analytical chemistry
    • Professor
    • Molecular Biotechnology Discipline
    • ProfessorMolecular Biotechnology Discipline

    Lana McClements is a highly motivated Lab Head of the Cardio-Obstetrics Research Group at UTS who is focused on women’s health as well as advocacy for women in STEM. In 2022, Lana was awarded a Heart Foundation Future Leader Fellowship to focus on her research program which aims to develop better monitoring strategies and treatments for preeclampsia, a cardiovascular disease in pregnant women, which can also lead to future cardiovascular and metabolic disease after pregnancy.

    In 2022, Lana was recognised for her work with a prestigious Newcastle Reproduction Emerging Research Leader Award from the Society for Reproductive Biology. Lana was awarded high commendation as an Emerging Health Researcher by BUPA Foundation in 2020. She was a finalist in the UTS Vice Chancellor’s Award for Research Excellence (Early Career Researcher 2020 and Research Development and Leadership 2021/2022) and the 2020 Johnson & Johnson Maternal Health Quickfire Challenge in the USA.

    Lana is working to develop a new test for preeclampsia. She leads a team that has patented new biomarkers able to predict the risk of preeclampsia early in pregnancy and identify cases of evolving preeclampsia. They recently developed a highly sensitive point-of-care diagnostic test based on these biomarkers. Currently there are no effective preventive or treatment strategies for preeclampsia short of preterm delivery of the baby.

    Lana’s team of eleven researchers are developing advanced 3D bioprinted and multicellular models of placental, vascular and heart tissue to better understand the mechanisms of pathogenesis of cardiovascular disease and evaluate new or emerging treatments.

    Lana is passionate about gender equality and women’s empowerment in academia and is Chair of the Faculty of Science Equity and Diversity Committee at UTS. Previously she led the Academic Women in Science (AWiS) network.

    She is a member of the NSW Cardiovascular Research Network (CVRN), Society for Reproductive Biology, Australian and New Zealand Placental Research Association (ANZPRA), Cardiac Society of Australia and New Zealand (CSANZ) and International Society for Heart Research (Australasia). She is honorary Senior Lecturer at Queen's University Belfast, Northern Ireland, UK.

    Disease areas of interest: Pre-eclampsia, Placental biology, Cardiovascular disease, Diabetes and Gestational diabetes mellitus

    - 3D bioprinted/multicellular models of placenta, fibrosis and heart disease
    - Placental development/biology
    - Cardiac health
    - Blood-based and tissue-based biomarkers (miRNA, circRNA, RNA, proteins)
    - Identification of disease mechanisms and targets
    - Stem cells biology and treatment (mesenchymal stem cells, cancer stem cells)
    - Transcriptomics and proteomics
    - Endothelial dysfunction/angiogenesis
    - Oxidative stress/anti-oxidants

    Other areas of research in the same disease areas:

    - Home monitoring/connected health
    /mHealth
    - Meta-analysis/systematic reviews
    - Service evaluations
    - Service development
    - Health and Gender inequalities
    - Global health.

    Lana McClements is a highly motivated Lab Head of the Cardio-Obstetrics Research Group at UTS who is focused on women’s health as well as advocacy for women in STEM. In 2022, Lana was awarded a Heart Foundation Future Leader Fellowship to focus on her research program which aims to develop better monitoring strategies and treatments for preeclampsia, a cardiovascular disease in pregnant women, which can also lead to future cardiovascular and metabolic disease after pregnancy.

    In 2022, Lana was recognised for her work with a prestigious Newcastle Reproduction Emerging Research Leader Award from the Society for Reproductive Biology. Lana was awarded high commendation as an Emerging Health Researcher by BUPA Foundation in 2020. She was a finalist in the UTS Vice Chancellor’s Award for Research Excellence (Early Career Researcher 2020 and Research Development and Leadership 2021/2022) and the 2020 Johnson & Johnson Maternal Health Quickfire Challenge in the USA.

    Lana is working to develop a new test for preeclampsia. She leads a team that has patented new biomarkers able to predict the risk of preeclampsia early in pregnancy and identify cases of evolving preeclampsia. They recently developed a highly sensitive point-of-care diagnostic test based on these biomarkers. Currently there are no effective preventive or treatment strategies for preeclampsia short of preterm delivery of the baby.

    Lana’s team of eleven researchers are developing advanced 3D bioprinted and multicellular models of placental, vascular and heart tissue to better understand the mechanisms of pathogenesis of cardiovascular disease and evaluate new or emerging treatments.

    Lana is passionate about gender equality and women’s empowerment in academia and is Chair of the Faculty of Science Equity and Diversity Committee at UTS. Previously she led the Academic Women in Science (AWiS) network.

    She is a member of the NSW Cardiovascular Research Network (CVRN), Society for Reproductive Biology, Australian and New Zealand Placental Research Association (ANZPRA), Cardiac Society of Australia and New Zealand (CSANZ) and International Society for Heart Research (Australasia). She is honorary Senior Lecturer at Queen's University Belfast, Northern Ireland, UK.

    Disease areas of interest: Pre-eclampsia, Placental biology, Cardiovascular disease, Diabetes and Gestational diabetes mellitus

    - 3D bioprinted/multicellular models of placenta, fibrosis and heart disease
    - Placental development/biology
    - Cardiac health
    - Blood-based and tissue-based biomarkers (miRNA, circRNA, RNA, proteins)
    - Identification of disease mechanisms and targets
    - Stem cells biology and treatment (mesenchymal stem cells, cancer stem cells)
    - Transcriptomics and proteomics
    - Endothelial dysfunction/angiogenesis
    - Oxidative stress/anti-oxidants

    Other areas of research in the same disease areas:

    - Home monitoring/connected health
    /mHealth
    - Meta-analysis/systematic reviews
    - Service evaluations
    - Service development
    - Health and Gender inequalities
    - Global health.

    • Academic
    • Masters Research or PhD student supervision
    Disciplines
    • Reproductive medicine
    • Visiting Scholar
    • School of Mathematical and Physical Sciences
    • Visiting ScholarSchool of Mathematical and Physical Sciences
    Dr. Sadraeian completed his Ph.D. in Biomolecular Physics with key contributions to Anti-HIV immunoconjugates. As a postdoc researcher, he conducted projects on anti-viral photoimmunotherapy and photodiagnostics.
    Dr. Sadraeian completed his Ph.D. in Biomolecular Physics with key contributions to Anti-HIV immunoconjugates. As a postdoc researcher, he conducted projects on anti-viral photoimmunotherapy and photodiagnostics.
    • Academic
    Disciplines
    • Biochemistry and cell biology not elsewhere classified
    • Medicinal and biomolecular chemistry
    • Medical biotechnology diagnostics (incl. biosensors)
    • Quantum optics and quantum optomechanics
    • Human biophysics
    • Associate Professor
    • Biomedical Engineering Discipline
    • Associate ProfessorBiomedical Engineering Discipline

    [Information updated Nov 2026]

     

    Trained as a biophysicist and microscopist, Dr QIAN (Peter) SU is currently an Emerging Leadership (EL2) Fellow of the Australian National Health and Medical Research Council (NHMRC), an Associate Professor in the School of Electrical, Mechanical and Biomedical Engineering at the University of Technology Sydney (UTS). Dr SU is also a Visiting Scientist at the Heart Research Institute (HRI) and Centenary Cancer Institute at the University of Sydney (USYD).


    In 2017, Peter received his PhD in Single-molecule Biophysics supervised by Biophysics world leaders Prof Xiaoliang Sunney XIE (Fellow of AAAS, OSA, BPS, APS) and Prof Yujie SUN (Distinguished Young Scholar, NSF) from the Biodynamic Optical Imaging Centre (now known as Biomedical Pioneering Innovation Centre, BIOPIC) at Peking University, with the honour of “Outstanding Graduate Student of the Beijing City”. In 2012, Peter took an overseas exchange scholarship and received training on super-resolution imaging in Profs X.S.XIE and Xiaowei ZHUANG (HHMI, Fellow of AAAS, APS) Groups at Harvard University. From 2017 to 2020, Dr SU joined the Institute for Biomedical Materials & Devices (IBMD) mentored by Prof Dayong JIN (ARC Laureate Fellow, FTSE, FAIMBE) and led the bio-imaging program at UTS.


    Dr QIAN SU is leading the laboratory of ‘Quantitative Imaging At Nanoscale with SUper-resolution (QIAN SU LAB)’, https://www.qiansulab.com/. The research program aims to bridge applied biomedical engineering with fundamental sciences and clinical requests. It brings new insights to biological and biomedical questions by advanced microscopy, with high spatial, temporal and thermal resolution. Peter has developed state-of-the-art biophysical nanotools to visualize the precise structures and pinpoint the molecular mechanisms during vital biological and medical processes:


    [Dynamic Imaging] developing advanced single-molecule imaging, tracking and manipulating systems to study motor and cytoskeleton-driven membrane dynamics and the underlying molecular mechanisms (Nat.CellBiol. 2015, Cell Res. 2015a, Sci.Rep. 2015, Dev.Cell 2016, PNAS 2017, Nat.Comms 2020, EMBORep 2020, Nat Photonics 2024, etc.);


    [Molecular Imaging] applying super-resolution microscopy to resolve the spatial-temporal distribution, organization and interactions of the hierarchical chromatin structures, DNA replication and transcription events in mammalian and bacterial cells (Nat.Comms 2014, CellRes. 2015b, PNAS 2020, GenBiol. 2021, MiMB 2023, eLife 2025, Cell Reports 2026, etc.);


    [Functional Imaging] deciphering the molecular interaction dynamics, termed “interactome”, for the mechanosensor integrin αIIbβ3 (GPIIb/IIIa) on blood clotting platelets, under clinical trialled drug (Nat.Comms 2018, Nat.Materials 2019, Euro. Bioph.J. 2022, Adv.Funct.Mat. 2023, Sci.Signaling 2023, Nat.Comms 2024, etc.). Pinpointing in vivo and in situ temperature dynamics in living cells and metabolic disease models (Chem.Sci. 2018, NanoLet. 2020/2021, PNAS 2022, etc.).

     

    [Information updated Nov 2026]

     

    Trained as a biophysicist and microscopist, Dr QIAN (Peter) SU is currently an Emerging Leadership (EL2) Fellow of the Australian National Health and Medical Research Council (NHMRC), an Associate Professor in the School of Electrical, Mechanical and Biomedical Engineering at the University of Technology Sydney (UTS). Dr SU is also a Visiting Scientist at the Heart Research Institute (HRI) and Centenary Cancer Institute at the University of Sydney (USYD).


    In 2017, Peter received his PhD in Single-molecule Biophysics supervised by Biophysics world leaders Prof Xiaoliang Sunney XIE (Fellow of AAAS, OSA, BPS, APS) and Prof Yujie SUN (Distinguished Young Scholar, NSF) from the Biodynamic Optical Imaging Centre (now known as Biomedical Pioneering Innovation Centre, BIOPIC) at Peking University, with the honour of “Outstanding Graduate Student of the Beijing City”. In 2012, Peter took an overseas exchange scholarship and received training on super-resolution imaging in Profs X.S.XIE and Xiaowei ZHUANG (HHMI, Fellow of AAAS, APS) Groups at Harvard University. From 2017 to 2020, Dr SU joined the Institute for Biomedical Materials & Devices (IBMD) mentored by Prof Dayong JIN (ARC Laureate Fellow, FTSE, FAIMBE) and led the bio-imaging program at UTS.


    Dr QIAN SU is leading the laboratory of ‘Quantitative Imaging At Nanoscale with SUper-resolution (QIAN SU LAB)’, https://www.qiansulab.com/. The research program aims to bridge applied biomedical engineering with fundamental sciences and clinical requests. It brings new insights to biological and biomedical questions by advanced microscopy, with high spatial, temporal and thermal resolution. Peter has developed state-of-the-art biophysical nanotools to visualize the precise structures and pinpoint the molecular mechanisms during vital biological and medical processes:


    [Dynamic Imaging] developing advanced single-molecule imaging, tracking and manipulating systems to study motor and cytoskeleton-driven membrane dynamics and the underlying molecular mechanisms (Nat.CellBiol. 2015, Cell Res. 2015a, Sci.Rep. 2015, Dev.Cell 2016, PNAS 2017, Nat.Comms 2020, EMBORep 2020, Nat Photonics 2024, etc.);


    [Molecular Imaging] applying super-resolution microscopy to resolve the spatial-temporal distribution, organization and interactions of the hierarchical chromatin structures, DNA replication and transcription events in mammalian and bacterial cells (Nat.Comms 2014, CellRes. 2015b, PNAS 2020, GenBiol. 2021, MiMB 2023, eLife 2025, Cell Reports 2026, etc.);


    [Functional Imaging] deciphering the molecular interaction dynamics, termed “interactome”, for the mechanosensor integrin αIIbβ3 (GPIIb/IIIa) on blood clotting platelets, under clinical trialled drug (Nat.Comms 2018, Nat.Materials 2019, Euro. Bioph.J. 2022, Adv.Funct.Mat. 2023, Sci.Signaling 2023, Nat.Comms 2024, etc.). Pinpointing in vivo and in situ temperature dynamics in living cells and metabolic disease models (Chem.Sci. 2018, NanoLet. 2020/2021, PNAS 2022, etc.).

     

    • Academic
    • Masters Research or PhD student supervision
    Disciplines
    • Biochemistry and cell biology
    • Oncology and carcinogenesis
    • Emeritus Professor
    • School of Life Sciences
    • Emeritus ProfessorSchool of Life Sciences

    Stella Valenzuela undertook her PhD studies in cell and molecular biology [identifying novel genes - CLIC1 and MIC-1 - from activated macrophage cells] at the Centre for Immunology (CFI), St Vincent's Hospital Sydney, obtaining her PhD from the University of NSW. Prior to this she had worked in the commercial sector, in the biotechnology companies Australian Monoclonal Development Pty Ltd and Cellabs Pty Ltd in research and development of monoclonal antibody technologies for research and diagnostic purposes. Following her PhD studies she was a Research Scientist at the CFI [functional studies of intracellular ion channel proteins - CLICs], later moving to the University of NSW to take up a position as an NHMRC Research Fellow [knockout mouse studies of S100 inflammatory proteins].

    She later joined the University of Technology (UTS), Key Centre for Health Technologies [cellular responses to mobile phone frequencies]. She served as the Director for the ARC Research Hub for Integrated Device for End-User Analysis at Low Levels (IDEAL Hub) at UTS. Previously she has also served as both Head of School and Associate Head of School (Research) in the School of Life Sciences, UTS. 

    Prof Valenzuela is a member of the Institute for Biomedical Materials and Devices and the Centre for Health Technologies and previously also a member of the Institute of Nanoscale Technologies, UTS. She has been instrumental in establishing Bionanotechnology research at UTS and has worked with her industry partner Surgical Diagnostics Pty Ltd, within the IDEAL HUB, an ARC Industry transformation hub, developing devices that use ion channel proteins and tethered membrane technologies and also partnered with Bod Science P/L developing proteins for use in cosmetic skin topical agents and for therapeutic purposes.

    Stella Valenzuela undertook her PhD studies in cell and molecular biology [identifying novel genes - CLIC1 and MIC-1 - from activated macrophage cells] at the Centre for Immunology (CFI), St Vincent's Hospital Sydney, obtaining her PhD from the University of NSW. Prior to this she had worked in the commercial sector, in the biotechnology companies Australian Monoclonal Development Pty Ltd and Cellabs Pty Ltd in research and development of monoclonal antibody technologies for research and diagnostic purposes. Following her PhD studies she was a Research Scientist at the CFI [functional studies of intracellular ion channel proteins - CLICs], later moving to the University of NSW to take up a position as an NHMRC Research Fellow [knockout mouse studies of S100 inflammatory proteins].

    She later joined the University of Technology (UTS), Key Centre for Health Technologies [cellular responses to mobile phone frequencies]. She served as the Director for the ARC Research Hub for Integrated Device for End-User Analysis at Low Levels (IDEAL Hub) at UTS. Previously she has also served as both Head of School and Associate Head of School (Research) in the School of Life Sciences, UTS. 

    Prof Valenzuela is a member of the Institute for Biomedical Materials and Devices and the Centre for Health Technologies and previously also a member of the Institute of Nanoscale Technologies, UTS. She has been instrumental in establishing Bionanotechnology research at UTS and has worked with her industry partner Surgical Diagnostics Pty Ltd, within the IDEAL HUB, an ARC Industry transformation hub, developing devices that use ion channel proteins and tethered membrane technologies and also partnered with Bod Science P/L developing proteins for use in cosmetic skin topical agents and for therapeutic purposes.

    • Academic
    • Masters Research or PhD student supervision
    Disciplines
    • Biochemistry and cell biology
    • Medicinal and biomolecular chemistry
    • Physical chemistry
    • Professor
    • Physics Discipline
    • ProfessorPhysics Discipline

    Dr Jiajia Zhou is a Professor at the Institute for Biomedical Materials & Devices (IBMD), University of Technology Sydney. She is internationally recognised for her outstanding research in upconversion photonics, luminescent nanothermometry, and optical bioimaging, advancing nanophotonic technologies for quantitative biological measurements and biomedical applications. Her interdisciplinary research integrates nanotechnology, photophysics, advanced microscopy, and biomedical engineering to develop next-generation optical probes, imaging platforms, and sensing technologies for quantitative measurements of cellular metabolism and rapid in vitro diagnostics of disease biomarkers. More recently, she has extended these technologies to the rapid detection of bacterial pathogens and the investigation of bacterial responses to antibiotic treatment through nanoscale temperature sensing, aiming to provide new insights into the fundamental mechanisms underlying antimicrobial resistance (AMR).

     

    Professor Zhou currently holds an Australian Research Council (ARC) Future Fellowship and a National Health and Medical Research Council (NHMRC) Emerging Leadership, and is a Chief Investigator in the ARC Centre of Excellence in Quantum Biotechnology (QUBIC). She has received prestigious awards, including the 2024 Australian Academy of Science Pawsey Medal, the 2022 David Syme Research Award, the 2019 Sturges Prize, and the 2018 Nanomaterials Young Investigator Award. She was also a finalist for the 2020 Australian Museum Eureka Prize for Emerging Leader in Science and the 2019 Australian Museum Eureka Prize for Outstanding Early Career Researcher. Professor Zhou has published more than 130 peer-reviewed papers, including articles in Nature, Nature Photonics, Nature Methods, Nature Reviews Physics, and Nature Communications. Her research has attracted over 10,000 citations.

    Dr Jiajia Zhou is a Professor at the Institute for Biomedical Materials & Devices (IBMD), University of Technology Sydney. She is internationally recognised for her outstanding research in upconversion photonics, luminescent nanothermometry, and optical bioimaging, advancing nanophotonic technologies for quantitative biological measurements and biomedical applications. Her interdisciplinary research integrates nanotechnology, photophysics, advanced microscopy, and biomedical engineering to develop next-generation optical probes, imaging platforms, and sensing technologies for quantitative measurements of cellular metabolism and rapid in vitro diagnostics of disease biomarkers. More recently, she has extended these technologies to the rapid detection of bacterial pathogens and the investigation of bacterial responses to antibiotic treatment through nanoscale temperature sensing, aiming to provide new insights into the fundamental mechanisms underlying antimicrobial resistance (AMR).

     

    Professor Zhou currently holds an Australian Research Council (ARC) Future Fellowship and a National Health and Medical Research Council (NHMRC) Emerging Leadership, and is a Chief Investigator in the ARC Centre of Excellence in Quantum Biotechnology (QUBIC). She has received prestigious awards, including the 2024 Australian Academy of Science Pawsey Medal, the 2022 David Syme Research Award, the 2019 Sturges Prize, and the 2018 Nanomaterials Young Investigator Award. She was also a finalist for the 2020 Australian Museum Eureka Prize for Emerging Leader in Science and the 2019 Australian Museum Eureka Prize for Outstanding Early Career Researcher. Professor Zhou has published more than 130 peer-reviewed papers, including articles in Nature, Nature Photonics, Nature Methods, Nature Reviews Physics, and Nature Communications. Her research has attracted over 10,000 citations.

    • Academic
    • Collaborative projects
    • Industry Projects
    • Masters Research or PhD student supervision
    • Career advice
    • Membership of an advisory committee
    Disciplines
    • Atomic, molecular and optical physics
    • Condensed matter physics
    • Materials engineering
    • Senior Lecturer
    • Biomedical Engineering Discipline
    • Senior LecturerBiomedical Engineering Discipline

    Dr Ying Zhu is a Senior Lecturer at the School of Biomedical Engineering, University of Technology Sydney (UTS), and the group leader of the Laboratory of In-Vitro NanoDiagnostics. She completed her PhD in optical biosensors in 2015 in Australia's leading biosensor and biodevice research group at UNSW, followed by postdoctoral training in clinical applications of biosensors at Dartmouth College's Thayer School of Engineering, US (2015–2017).

     

    Dr Zhu's research develops next-generation molecular tools for precision diagnostics, harnessing the unique optical properties of nanoscale materials to generate molecular evidence that enables precise and timely clinical decisions. Currently, she leads two integrated research streams: building ultrasensitive nanophotonic biosensing platforms and applying these new analytical technologies to clinically meaningful new biomarkers, particularly extracellular vesicles (EVs)- nanoscale particles shed by tumour cells that carry molecular fingerprints of disease.

     

    Ranked 3rd in Australia for nanoplasmonic biosensing (SciVal), Dr Zhu has produced 33 publications garnering >1,300 citations (h-index 20), including a top 1% highly cited paper cited in an international clinical guideline. She has secured $2.68M in research funding as lead investigator on all 10 projects, including an ARC DECRA (2024), Cancer Institute NSW Early Career Fellowship (2017), 3 PanKind Innovation Grants, and three UTS Capital Expenditure Bids in research infrastructure. Her international standing is recognised by the 2025 Royal Society of Chemistry Sensors and Diagnostics Emerging Investigator Award, invitations to speak at the ISEV Annual Meeting Education Day as one of only three Australian speakers, and iCANX Talks, reaching a global audience of 16,400.

     

    Dr Zhu serves as founding Associate Editor for Biosensors and Biomolecular Electronics (Springer Nature), Associate Editor for Cytometry Part A (Wiley), the only Australian on the Board Reviewers panel of the Journal of Extracellular Vesicles and an affiliated researcher of the ARC Research Hub for Molecular Biosensors at Point-of-Use (MOBIUS). She has supervised 30+ students, with 3 PhD completions, and has mentored 3 early-career researchers to secure ARC DECRA fellowships.

     

    Dr Zhu's interdisciplinary approach spans chemistry, physics, materials science, nanotechnology, and biomedicine. She is committed to advancing innovative analytical technologies through highly collaborative, cross-disciplinary research, bridging the gap between molecular discovery and clinical impact.

     

    Learn more about Dr Zhu's work here. 

    Dr Ying Zhu is a Senior Lecturer at the School of Biomedical Engineering, University of Technology Sydney (UTS), and the group leader of the Laboratory of In-Vitro NanoDiagnostics. She completed her PhD in optical biosensors in 2015 in Australia's leading biosensor and biodevice research group at UNSW, followed by postdoctoral training in clinical applications of biosensors at Dartmouth College's Thayer School of Engineering, US (2015–2017).

     

    Dr Zhu's research develops next-generation molecular tools for precision diagnostics, harnessing the unique optical properties of nanoscale materials to generate molecular evidence that enables precise and timely clinical decisions. Currently, she leads two integrated research streams: building ultrasensitive nanophotonic biosensing platforms and applying these new analytical technologies to clinically meaningful new biomarkers, particularly extracellular vesicles (EVs)- nanoscale particles shed by tumour cells that carry molecular fingerprints of disease.

     

    Ranked 3rd in Australia for nanoplasmonic biosensing (SciVal), Dr Zhu has produced 33 publications garnering >1,300 citations (h-index 20), including a top 1% highly cited paper cited in an international clinical guideline. She has secured $2.68M in research funding as lead investigator on all 10 projects, including an ARC DECRA (2024), Cancer Institute NSW Early Career Fellowship (2017), 3 PanKind Innovation Grants, and three UTS Capital Expenditure Bids in research infrastructure. Her international standing is recognised by the 2025 Royal Society of Chemistry Sensors and Diagnostics Emerging Investigator Award, invitations to speak at the ISEV Annual Meeting Education Day as one of only three Australian speakers, and iCANX Talks, reaching a global audience of 16,400.

     

    Dr Zhu serves as founding Associate Editor for Biosensors and Biomolecular Electronics (Springer Nature), Associate Editor for Cytometry Part A (Wiley), the only Australian on the Board Reviewers panel of the Journal of Extracellular Vesicles and an affiliated researcher of the ARC Research Hub for Molecular Biosensors at Point-of-Use (MOBIUS). She has supervised 30+ students, with 3 PhD completions, and has mentored 3 early-career researchers to secure ARC DECRA fellowships.

     

    Dr Zhu's interdisciplinary approach spans chemistry, physics, materials science, nanotechnology, and biomedicine. She is committed to advancing innovative analytical technologies through highly collaborative, cross-disciplinary research, bridging the gap between molecular discovery and clinical impact.

     

    Learn more about Dr Zhu's work here. 

    • Academic
    • Masters Research or PhD student supervision
    Disciplines
    • Cancer diagnosis
    • Medical biotechnology diagnostics (incl. biosensors)
    • Nanotechnology